GlassScriptPhysician profile
Stephen W Kayota
NPI 1083687099
$3,230.59
in general payments reported to CMS, 2019-2025
20 companies · $307 in 2025
The $307 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $356 · 2021: $1,458 · 2022: $233 · 2023: $539 · 2024: $338 · 2025: $307.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,184.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,183.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $1,181.82 | 2021 | |
| Collegium Pharmaceutical, INC. | $905.05 | 2019-2025 | Belbuca, Xtampza, Belbuca |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $345.26 | 2021-2024 | Relistor |
| Averitas Pharma INC. | $111.96 | 2023-2024 | Qutenza |
| Pfizer INC. | $97.19 | 2019-2021 | |
| Grt US Holding, INC. | $90.00 | 2021-2022 | |
| Tonix Medicines, INC. | $84.05 | 2025 | |
| Nevro Corp. | $71.59 | 2019 | |
| Scilex Pharmaceuticals INC. | $53.01 | 2019 | |
| Electronic Waveform Lab, INC. | $46.09 | 2019-2024 | |
| Emergent Biosolutions INC. | $45.00 | 2021 | |
| Biodelivery Sciences International, INC. | $44.97 | 2021 | |
| Abbvie INC. | $35.79 | 2021 | |
| Kaleo, INC. | $32.80 | 2019 | |
| Daiichi Sankyo INC. | $26.15 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertical Pharmaceuticals, LLC | $18.29 | 2019 | |
| Pacira Therapeutics, INC. | $15.59 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $15.19 | 2019 | |
| Shionogi INC | $10.79 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Kayota listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.